Haleon plc (HLN) Stock Grade

About Haleon plc's fundamentals

Haleon is a $42.7 billion healthcare company with a net profit margin of 14.8%, indicating solid profitability on its revenue base, though the company experienced a 1.8% year-over-year revenue decline. The stock trades at a P/E ratio of 20.6, which is moderate for the healthcare sector, while generating a 3.2% dividend yield for shareholders. Return on equity stands at 9.9%, suggesting the company generates modest returns on shareholder capital deployed in the business.